ReviewJournal of molecular medicine (Berlin, Germany)2024

Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer.

Rafaela Nasser Veiga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.